148 research outputs found
Uveal melanoma dissemination within the scleral tract in fine needle aspiration biopsy
Introduction. Fine needle aspiration biopsy (FNAB) of uveal melanoma (UM) is an invasive procedure. Many authors consider UM FNAB to be safe procedure, however extraocular extension of the tumor through the scleral tracts may occur. Current studies of scleral tracts after FNAB do not compare different biopsy techniques (cannula-assisted and without cannula) in terms of UM cells.Purpose. To assess morphology of scleral tracts for the presence of malignant cells when different biopsy techniques are approached.Material and methods. Forty-four scleral samples were analyzed after transvitreal FNAB performed in 22 enucleated eyes with UM. Cannula-assisted FNAB was performed in 22 cases. In the same eyes FNAB (n=22) was performed without cannula.Results. FNAB material was adequate for cytological examination in all cases. UM was confirmed in 22 eyes pathologically. UM cell implantation was detected in 5 scleral samples after FNAB without cannula. No signs of cell implantation were seen after cannula-assisted FNAB. The risk of scleral tract UM cell implantation was statistically lower in cannula-assisted FNAB technique (p=0.018, Pearson Chi-square test).Conclusions. UM FNAB performed directly through the sclera without cannula is associated with tumor cells implantation in scleral tract. Cannula-assisted FNAB significantly reduces the incidence of UM implantation in scleral tract
The Hitting Times with Taboo for a Random Walk on an Integer Lattice
For a symmetric, homogeneous and irreducible random walk on d-dimensional
integer lattice Z^d, having zero mean and a finite variance of jumps, we study
the passage times (with possible infinite values) determined by the starting
point x, the hitting state y and the taboo state z. We find the probability
that these passages times are finite and analyze the tails of their cumulative
distribution functions. In particular, it turns out that for the random walk on
Z^d, except for a simple (nearest neighbor) random walk on Z, the order of the
tail decrease is specified by dimension d only. In contrast, for a simple
random walk on Z, the asymptotic properties of hitting times with taboo
essentially depend on the mutual location of the points x, y and z. These
problems originated in our recent study of branching random walk on Z^d with a
single source of branching
Gamma Knife stereotactic radiosurgery for intraocular retinoblastoma: a 5-year experience
External beam radiotherapy (EBR) remained for a long time the only method of treatment in children with recurrent and resistant retinoblastoma (RB). This method often leads to serious complications, including the occurrence of secondary malignant tumors. Currently, EBR is used as second-line (salvage) therapy. There is no data in the literature of using Gamma Knife stereotactic radiosurgery (GKRS) in RB treatment.Purpose. To present 5-year experience of using GKRS in patients with RB.Material and methods. 16 children (17 eyes) were treated using GKRS in the period from 2015 to 2019. Mean patient age was 34.7 months (range, 12β114 months). The eyes were classified as group B (n=4), C (n=1), D (n=12). 3 children had the last eye. All patients received systemic and local chemotherapy, all types of local treatment modalities before using GKRS. Recurrent and resistant RB was the indication for GKRS. Marginal 50% mean dose was 22 GΡ (range, 20β24 GΡ), depending on tumour type and location. Radiation doses were evaluated accounting critical eye structures and the orbit bones.Results. Complete regression was achieved in 11 patients, partial in 2. Four patients underwent enucleation after GKRS. Indications for enucleation were retinoblastoma recurrence (n=2) and vitreous hemorrhage with total retinal detachment (n=2). 13 eyes were salvaged with no signs of keratopathy, uveitis or damage of orbital and surrounding tissues during mean follow-up 30.6 months (range, 7β60 months). Π‘omplications of different severity occurred in 13 patients, including vitreous hemorrhage in 6 patients, which was successfully treated both conservative (n=3) and using pars plana vitrectomy with simultaneous melphalan irrigation (n=3).Conclusion. The first experience of GKRS as an alternative to enucleation in patients with RB was proved to be reasonable and successful
Single-stage combined urethroplasty for extended strictures of the anterior urethra of tuberculous origin
Background. Urethral strictures are currently one of the most complex pathologies in reconstructive urology. The most promising direction in this area is the development of single-stage surgical interventions that meets modern requirements for the quality of life of patients.The aim of the study. To evaluate the possibility and the effectiveness of surgical treatment of extended recurrent tuberculous urethral strictures in men using a combination of a skin flap and a buccal graft. In the literature, there is no description of the use of this technique in patients with urethral tuberculosis.Materials and methods. We observed 44 patients with urethral tuberculosis. Three men from this group of patients were diagnosed with tuberculous (post-tuberculous) extended recurrent stricture of the anterior urethra and they underwent combined single-stage urethroplasty with a ventral fasciocutaneous flap and a buccal graft using the inlay method in the penile region and with a buccal graft using the ventral onlay method in the bulbous urethra. Ultrasound of the urethra served as a method that determines the possibility of performing this surgery in case of maintaining a sufficient width of the urethral plate with a moderate degree of spongiofibrosis.Results. Patients were under observation for 34, 50 and 54 months and have good long-term functional results β all patients have unassisted urination and no residual urine. Post-micturition dribbling persists in 1 patient. The overall effectiveness of the treatment of these strictures, taking into account the treatment of repeated cases of the disease recurrence, is high.Conclusion. This technique demonstrates the possibility of performing a single-stage reconstruction of the anterior urethra in patients with extended recurrent tuberculous (post-tuberculous) urethral strictures and is also applicable for the surgical treatment of urethral strictures of other origins
Survival prognosis in individuals with a high spatial QRS-T angle
Aim. To evaluate medium-term survival without irreversible and fatal cardiovascular events in individuals with a high spatial QRS-T angle (sQRS-Ta) from a regional Russian sample.Material and methods. We analyzed 1394 electrocardiographic records from a random regional sample of men (30%) and women aged 25-64, which were included in the ESSE-RF1 study. Women were on average 5 years older than men, but there was no difference in mean age in the 45-64 groups. The follow-up period lasted 7 year; 26 irreversible events (cardiovascular death, non-fatal myocardial infarction or stroke) and 63 composite endpoints (CEs) (irreversible event or heart failure progression or revascularization) were identified. Irreversible events and composite endpoint in men were noted more often than in women as follows: 3,7% vs 1,1% (p=0,003) and 6,9% vs 3,6% (p=0,01), respectively. sQRS-Ta was estimated as the angle between the integral QRS and T vectors in the orthogonal leads. Survival was assessed by Kaplan-Meier curves using a log-rank test. Differences were considered significant at pβ€0,05.Β Results. Sex groups did not differ in mean sQRS-Ta. sQRS-Ta β₯90o was considered to be increased. The divergence of survival curves by the end of follow-up period in men with increased sQRS-Ta relative to men with sQRS-Ta <900 was greater than in women as follows: 0,88 vs 0,96 for CE (p=0,0026) and 0,93 vs 0,96 for irreversible events (p=0,009); in women β 0,94 vs 0,98 for CE only (p=0,0016). Initial event and CE in men with increased sQRS-Ta occurred earlier than those with normal sQRS-Ta and then in women with increased sQRS-Ta. There were no differences in the frequency of sQRS-Ta increase among 45-64-year-old men and women, but irreversible events in men with increased sQRS-Ta occurred 5 times more often than in women. According to two-stage logistic regression, the probability of irreversible event in men is 4,35 times higher than in women (p=0,0002). After adjusting for sex, in individuals with increased sQRS-Ta, it is 2,75 times higher than in individuals with sQRS-Ta <90o (p=0,015).Conclusion. In men with increased sQRS-Ta (β₯90o), survival without irreversible and fatal cardiovascular events was worse, and life expectancy was shorter than in men with normal sQRS-Ta or women with increased sQRS-Ta. The prognosis of irreversible events was significantly affected by male sex and sQRS-Ta increase
ΠΡΠ΅Π½ΠΊΠ° ΡΠΈΡΠΊΠ° ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ Β«ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉΒ» ΡΠΎΠ½ΠΊΠΎΠΈΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π°ΡΠΏΠΈΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ Π±ΠΈΠΎΠΏΡΠΈΠΈ ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ
Despite the widespread u se of fine-needle aspiration biopsy (FNAB) of uveal melanoma (UM) for prognostic purposes, there are still doubts about the safety of this procedure. No analysis of such data can be found in domestic literature, and foreign authors have published only a few papers on this issue.The purpose of this study is to analyze the risk of metastasis in patients with UM during FNAB.Two groups of patients were formed: the main group, where FNAB was performed during brachytherapy (BT) (BT + FNAB) (n = 70), and the control group, where only BT was performed (n = 144).According to the obtained data, the probability of metastases during a 3βyear follow-up period did not significantly differ between the two groups (p = 0.22 by Fisher's exact test and p = 0.11 by log-rank test when assessing survival using the Kaplan β Meier method), the relative risk (RR) was 1.43 [95 % CI 0.79 to 2.24]. In addition, there was no significant difference in the main clinical outcomes of local treatment associated with worse prognosis: the degree of tumor regression (p = 0.46), extrascleral growth, the need for additional brachytherapy (p = 0.32) or secondary enucleation (p = 0.99).The absence of a significant difference in patient survival between the BT and BT + FNAB groups opens up prospects for a more extensive use of FNAB in patients with UM for prognostic purposes.ΠΠ½Π½ΠΎΡΠ°ΡΠΈΡ: ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° ΡΠΈΡΠΎΠΊΠΎΠ΅ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΎΠ½ΠΊΠΎΠΈΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π°ΡΠΏΠΈΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ Π±ΠΈΠΎΠΏΡΠΈΠΈ (Π’ΠΠΠ) ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ (Π£Π) Ρ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅Π»ΡΡ, Π΄ΠΎ ΡΠΈΡ
ΠΏΠΎΡ Π²ΡΡΠΊΠ°Π·ΡΠ²Π°ΡΡΡΡ ΡΠΎΠΌΠ½Π΅Π½ΠΈΡ Π² Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΠΈ ΡΡΠΎΠΉ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ. ΠΡΠΈ ΡΡΠΎΠΌ Π² ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ΅ Π°Π½Π°Π»ΠΈΠ· ΡΠ°ΠΊΠΈΡ
Π΄Π°Π½Π½ΡΡ
Π½Π΅ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΡΡ, Π° ΡΡΠ΅Π΄ΠΈ Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΡΡ
Π°Π²ΡΠΎΡΠΎΠ² ΠΏΠΎ ΡΡΠΎΠΉ ΡΠ΅ΠΌΠ΅ Π²ΡΡΡΠ΅ΡΠ°ΡΡΡΡ Π»ΠΈΡΡ Π΅Π΄ΠΈΠ½ΠΈΡΠ½ΡΠ΅ ΡΠ°Π±ΠΎΡΡ.Π¦Π΅Π»Ρ: ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ Π°Π½Π°Π»ΠΈΠ·Π° ΡΠΈΡΠΊΠ° ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π£Π ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ Π’ΠΠΠ.ΠΡΠ»ΠΈ ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½Ρ 2 Π³ΡΡΠΏΠΏΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²: ΠΎΡΠ½ΠΎΠ²Π½Π°Ρ, Π³Π΄Π΅ ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ Π±ΡΠ°Ρ
ΠΈΡΠ΅ΡΠ°ΠΏΠΈΠΈ (ΠΠ’) ΠΎΠ΄Π½ΠΎΠΌΠΎΠΌΠ΅Π½ΡΠ½ΠΎ Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΈ Π’ΠΠΠ (ΠΠ’ + Π’ΠΠΠ) (n = 70), ΠΈ ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ, Π³Π΄Π΅ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ ΡΠΎΠ»ΡΠΊΠΎ ΠΠ’ (n = 144).Π‘ΠΎΠ³Π»Π°ΡΠ½ΠΎ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠΌ Π΄Π°Π½Π½ΡΠΌ, Π²Π΅ΡΠΎΡΡΠ½ΠΎΡΡΡ Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΡ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΎΠ² Π² ΠΏΠ΅ΡΠΈΠΎΠ΄ 3βΠ»Π΅ΡΠ½Π΅Π³ΠΎ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ Π² ΠΎΠ±Π΅ΠΈΡ
Π³ΡΡΠΏΠΏΠ°Ρ
Π½Π΅ ΠΈΠΌΠ΅Π΅Ρ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎΠΉ ΡΠ°Π·Π½ΠΈΡΡ (p = 0,22 ΠΏΠΎ ΡΠΎΡΠ½ΠΎΠΌΡ ΠΊΡΠΈΡΠ΅ΡΠΈΡ Π€ΠΈΡΠ΅ΡΠ° ΠΈ p = 0,11 ΠΏΠΎ Π»ΠΎΠ³Π°ΡΠΈΡΠΌΠΈΡΠ΅ΡΠΊΠΎΠΌΡ ΡΠ°Π½Π³ΠΎΠ²ΠΎΠΌΡ ΠΊΡΠΈΡΠ΅ΡΠΈΡ ΠΏΡΠΈ ΠΎΡΠ΅Π½ΠΊΠ΅ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ°ΠΏΠ»Π°Π½Π° β ΠΠ°ΠΉΠ΅ΡΠ°), ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΡΠΈΡΠΊ (RR) ΡΠΎΡΡΠ°Π²ΠΈΠ» 1,43 (95 % Π΄ΠΎΠ²Π΅ΡΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΠ²Π°Π» ΠΎΡ 0,79 Π΄ΠΎ 2,24). ΠΡΠΎΠΌΠ΅ ΡΠΎΠ³ΠΎ, Π½Π΅ ΠΎΡΠΌΠ΅ΡΠ°Π»ΠΎΡΡ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎΠΉ ΡΠ°Π·Π½ΠΈΡΡ ΠΏΡΠΈ ΠΎΡΠ΅Π½ΠΊΠ΅ ΠΎΡΠ½ΠΎΠ²Π½ΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΡΡ
ΠΎΠ΄ΠΎΠ² Π»ΠΎΠΊΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Ρ ΡΡ
ΡΠ΄ΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΡΠΎΠ³Π½ΠΎΠ·Π°: ΡΡΠ΅ΠΏΠ΅Π½Ρ ΡΠ΅Π³ΡΠ΅ΡΡΠΈΠΈ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ (p = 0,46), ΡΠΊΡΡΡΠ°ΡΠΊΠ»Π΅ΡΠ°Π»ΡΠ½ΡΠΉ ΡΠΎΡΡ, Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ Π±ΡΠ°Ρ
ΠΈΡΠ΅ΡΠ°ΠΏΠΈΠΈ (p = 0,32) ΠΈΠ»ΠΈ Π²ΡΠΎΡΠΈΡΠ½ΠΎΠΉ ΡΠ½ΡΠΊΠ»Π΅Π°ΡΠΈΠΈ (p = 0,99).ΠΡΡΡΡΡΡΠ²ΠΈΠ΅ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎΠΉ ΡΠ°Π·Π½ΠΈΡΡ Π² Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² Π³ΡΡΠΏΠΏΠ°Ρ
ΠΠ’ ΠΈ ΠΠ’ + Π’ΠΠΠ ΠΎΡΠΊΡΡΠ²Π°Π΅Ρ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Ρ Π΄Π»Ρ Π±ΠΎΠ»Π΅Π΅ ΠΌΠ°ΡΡΡΠ°Π±Π½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π’ΠΠΠ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π£Π Ρ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅Π»ΡΡ
ΠΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΠΈ Π°Π±Π΅ΡΡΠ°ΡΠΈΠΉ Ρ ΡΠΎΠΌΠΎΡΠΎΠΌΡ 8 Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠΎΠΉ
Introduction. Uveal melanoma ability to metastasize depends on a few prognostic factors. The genetic ones are considered to be the most significant. The role of disorders of the short arm of chromosome 8 (8p), as well as a combination of changes in 8p and the long arm of this chromosome (8q) in the development of metastatic lesions in this pathology remains insufficiently studied.The study objective β to evaluate the prognostic value of chromosome 8 abnormalities in patients with uveal melanoma.Materials and methods. We analyzed 2 retrospective groups of patients who underwent enucleation for uveal melanoma, statistically homogeneous in the main clinical parameters. Group 1 included patients without signs of metastases (n = 41) with an average follow-up period of 71 months, Group 2 included patients with detected metastases (n = 51) and an average follow-up period of 21 months Chromosome abnormalities were tested by multiplex ligation-dependent probe amplification.Results. Three- and five-year survival in patients with uveal melanoma without 8p deletion were 64 and 54 %, respectively; with 8p deletion significantly lower β 25 and 6 %, respectively. The same survival rates in patients with uveal melanoma with 8q amplification were 43 and 26 %, respectively, whereas in patients without 8q amplification they were significantly higher β 80 and 74 %, respectively. In patients with uveal melanoma harbouring both abnormalities, 3- and 5-year survival rates were 26 and 7 %, whereas isolated 8q amplification was associated with 47 and 35 % survival, respectively. These survival rates differ greatly and significantly: hazard ratio 3,26 (95 % confidence interval 1,86β5,69) and 6,89 (95 % confidence interval 2,67β17,73), respectively (Ρ <0,0001).Conclusion. The findings support comprehensive evaluation of chromosome 8 abnormalities as a substantial part of uveal melanoma prognostication. 8q amplification, 8p deletion, combination of these abnormalities and its role in uveal melanoma malignity should be further discovered. Further research in this direction is needed.ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. Π‘ΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡ ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ ΠΊ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π·Π°Π²ΠΈΡΠΈΡ ΠΎΡ ΡΠ΅Π»ΠΎΠ³ΠΎ ΡΠΏΠ΅ΠΊΡΡΠ° ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ², ΡΡΠ΅Π΄ΠΈ ΠΊΠΎΡΠΎΡΡΡ
Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΠΌΠ΅ΡΡ ΠΎΡΠ½ΠΎΠ²ΠΎΠΏΠΎΠ»Π°Π³Π°ΡΡΠ΅Π΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅. Π ΠΎΠ»Ρ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ ΠΊΠΎΡΠΎΡΠΊΠΎΠ³ΠΎ ΠΏΠ»Π΅ΡΠ° Ρ
ΡΠΎΠΌΠΎΡΠΎΠΌΡ 8 (8Ρ), Π° ΡΠ°ΠΊΠΆΠ΅ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠΈΠΈ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ 8Ρ ΠΈ Π΄Π»ΠΈΠ½Π½ΠΎΠ³ΠΎ ΠΏΠ»Π΅ΡΠ° ΡΡΠΎΠΉ Ρ
ΡΠΎΠΌΠΎΡΠΎΠΌΡ (8q) Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΠΌΠ΅ΡΠ°ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ ΠΏΡΠΈ Π΄Π°Π½Π½ΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΎΡΡΠ°Π΅ΡΡΡ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎ ΠΈΠ·ΡΡΠ΅Π½Π½ΠΎΠΉ.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΠΈ Π°Π±Π΅ΡΡΠ°ΡΠΈΠΉ Ρ
ΡΠΎΠΌΠΎΡΠΎΠΌΡ 8 Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠΎΠΉ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΠ»ΠΈ ΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ 2 ΡΠ΅ΡΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠ΅ Π³ΡΡΠΏΠΏΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², ΠΊΠΎΡΠΎΡΡΠΌ Π±ΡΠ»Π° ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π° ΡΠ½ΡΠΊΠ»Π΅Π°ΡΠΈΡ ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρ ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ, ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ ΠΎΠ΄Π½ΠΎΡΠΎΠ΄Π½ΡΠ΅ ΠΏΠΎ ΠΎΡΠ½ΠΎΠ²Π½ΡΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠ°ΠΌ. Π 1-Ρ Π³ΡΡΠΏΠΏΡ Π²ΠΎΡΠ»ΠΈ Π±ΠΎΠ»ΡΠ½ΡΠ΅ Π±Π΅Π· ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ² ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΎΠ² (n = 41) ΡΠΎ ΡΡΠ΅Π΄Π½ΠΈΠΌ ΡΡΠΎΠΊΠΎΠΌ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ 71 ΠΌΠ΅Ρ, Π²ΠΎ 2-Ρ Π³ΡΡΠΏΠΏΡ β Π±ΠΎΠ»ΡΠ½ΡΠ΅ Ρ Π²ΡΡΠ²Π»Π΅Π½Π½ΡΠΌΠΈ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·Π°ΠΌΠΈ (n = 51) ΠΈ ΡΡΠ΅Π΄Π½ΠΈΠΌ ΡΡΠΎΠΊΠΎΠΌ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ 21 ΠΌΠ΅Ρ. Π°Π½Π°Π»ΠΈΠ· Ρ
ΡΠΎΠΌΠΎΡΠΎΠΌΠ½ΡΡ
Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΌΡΠ»ΡΡΠΈΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠΉ Π°ΠΌΠΏΠ»ΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Π»ΠΈΠ³ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π·ΠΎΠ½Π΄ΠΎΠ².Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π’ΡΠ΅Ρ
- ΠΈ 5-Π»Π΅ΡΠ½ΡΡ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠΎΠΉ Π±Π΅Π· Π΄Π΅Π»Π΅ΡΠΈΠΈ 8p ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 64 ΠΈ 54 %, Ρ Π΄Π΅Π»Π΅ΡΠΈΠ΅ΠΉ 8p β 25 ΠΈ 6 % ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ. Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ Π°ΠΌΠΏΠ»ΠΈΡΠΈΠΊΠ°ΡΠΈΠ΅ΠΉ 8q ΡΡΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π±ΡΠ»ΠΈ ΡΠ°Π²Π½Ρ 43 ΠΈ 26 %, Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π±Π΅Π· Π°ΠΌΠΏΠ»ΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ 8q β 80 ΠΈ 74 % ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ. ΠΠ»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΎΠ΄Π½ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ Π°ΠΌΠΏΠ»ΠΈΡΠΈΠΊΠ°ΡΠΈΠ΅ΠΉ ΡΠ΅Π³ΠΈΠΎΠ½Π° 8q ΠΈ Π΄Π΅Π»Π΅ΡΠΈΠ΅ΠΉ ΡΠ΅Π³ΠΈΠΎΠ½Π° 8Ρ 3- ΠΈ 5-Π»Π΅ΡΠ½ΡΡ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 26 ΠΈ 7 %, ΡΠΎΠ³Π΄Π° ΠΊΠ°ΠΊ Π΄Π»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Π°ΠΌΠΏΠ»ΠΈΡΠΈΠΊΠ°ΡΠΈΠ΅ΠΉ 8q β 47 ΠΈ 35 % ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ. Π£ΡΠΎΠ²Π΅Π½Ρ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Π°ΠΌΠΏΠ»ΠΈΡΠΈΠΊΠ°ΡΠΈΠ΅ΠΉ 8q ΠΈ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠΈΠ΅ΠΉ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ (del8p + amp8q) ΡΠ°Π·Π»ΠΈΡΠ°Π΅ΡΡΡ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ ΠΈ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ: ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅ ΡΠΈΡΠΊΠΎΠ² 3,26 (95 % Π΄ΠΎΠ²Π΅ΡΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΠ²Π°Π» 1,86β5,69) ΠΈ 6,89 (95 % Π΄ΠΎΠ²Π΅ΡΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΠ²Π°Π» 2,67β17,73) (Ρ <0,0001).ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠ΅Π½ΠΊΠ° Π°ΠΌΠΏΠ»ΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ 8q, Π΄Π΅Π»Π΅ΡΠΈΠΈ 8p ΠΈ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠΈΠΈ ΡΡΠΈΡ
Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ Π΄ΠΎΠ»ΠΆΠ½Π° ΡΡΠ°ΡΡ Π½Π΅ΠΎΡΡΠ΅ΠΌΠ»Π΅ΠΌΠΎΠΉ ΡΠ°ΡΡΡΡ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠΈΡΠΊΠ° ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ. ΠΠ΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΡ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠΈΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π² ΡΡΠΎΠΌ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠΈ
ΠΠ½Π°Π»ΠΈΠ· ΠΏΠΎΡΡΠ΅Π±Π½ΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠΎΠΉ Π² ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΠΎΠΌ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΡΠΈΡΠΊΠ° ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ
Molecular-genetic study of uveal melanoma (UM) is crucial in predicting the risk of metastasis of this tumor. Such analysis is also possible during organ-sparing treatment based on fine-needle aspiration biopsy (FNAB), however, not all patients may consider this study appropriate and/or accessible.The goal of this study was to analyze the needs of patients with UM for individual metastasis risk prognosis.This retrospective cohort study was conducted using a questionnaire in 94 patients with UM (mean age 60 Β± 13 years; 69 % women and 31 % men). Despite the rather high proportion of interested patients (77 %), only half (51 %) of them ultimately agreed to undergo a βprognosticβ FNAB, which was primarily due to the high cost of this study (it was the main reason for refusal in 76 % of cases). Patients were mainly motivated to know their risk by: a sense of control of the situation and the possibility of taking preventive measures (78 %), future planning for themselves and/or their loved ones (47 %), the possibility of participating in metastatic UM treatment programs (35 %), receiving the maximum amount of information about the disease (28 %). Patients without such intention cited a fear of revealing a high risk of metastases and an impossibility of psychological stabilization based on results of this test.Predicting the risk of metastasis is an important component of an integrated approach to the management of patients with uveal melanoma, including organ-sparing treatment. State funding of this study will increase the satisfaction of psychological needs in this category of cancer patients and improve understanding of the metastasis of uveal melanoma.ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ (Π£Π) ΠΈΠΌΠ΅Π΅Ρ ΡΠ΅ΡΠ°ΡΡΠ΅Π΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ Π² ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΡΠΈΡΠΊΠ° ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΡΠΎΠΉ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ. Π’Π°ΠΊΠΎΠΉ Π°Π½Π°Π»ΠΈΠ· Π²ΠΎΠ·ΠΌΠΎΠΆΠ΅Π½ Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ ΠΎΡΠ³Π°Π½ΠΎΡΠΎΡ
ΡΠ°Π½ΡΡΡΠ΅Π³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ Π½Π° ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π΅ ΡΠΎΠ½ΠΊΠΎΠΈΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π°ΡΠΏΠΈΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ Π±ΠΈΠΎΠΏΡΠΈΠΈ (Π’ΠΠΠ), ΠΎΠ΄Π½Π°ΠΊΠΎ Π½Π΅ Π²ΡΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ ΠΌΠΎΠ³ΡΡ ΡΡΠΈΡΠ°ΡΡ Π΄Π°Π½Π½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ΅Π»Π΅ΡΠΎΠΎΠ±ΡΠ°Π·Π½ΡΠΌ ΠΈ/ΠΈΠ»ΠΈ Π΄ΠΎΡΡΡΠΏΠ½ΡΠΌ.Π¦Π΅Π»Ρ: ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ Π°Π½Π°Π»ΠΈΠ·Π° ΠΏΠΎΡΡΠ΅Π±Π½ΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π£Π Π² ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΠΎΠΌ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΎΠ².ΠΠ°Π½Π½ΠΎΠ΅ ΡΠ΅ΡΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ ΠΊΠΎΠ³ΠΎΡΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΎΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π°Π½ΠΊΠ΅ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ 94 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π£Π (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ 60 Β± 13 Π»Π΅Ρ; 69 % ΠΆΠ΅Π½ΡΠΈΠ½ ΠΈ 31 % ΠΌΡΠΆΡΠΈΠ½).ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎ Π²ΡΡΠΎΠΊΠΎΠ΅ ΡΠΈΡΠ»ΠΎ ΠΆΠ΅Π»Π°ΡΡΠΈΡ
(77 %), ΡΠΎΠ»ΡΠΊΠΎ ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Π° (51 %) ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΠΌ ΡΡΠ΅ΡΠ΅ Π±ΡΠ»ΠΈ ΡΠΎΠ³Π»Π°ΡΠ½Ρ Π½Π° ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ Β«ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉΒ» Π’ΠΠΠ, ΡΡΠΎ Π² ΠΏΠ΅ΡΠ²ΡΡ ΠΎΡΠ΅ΡΠ΅Π΄Ρ ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½ΠΎ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΡΠΎΠΈΠΌΠΎΡΡΡΡ Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ (Π² 76 % ΡΠ²Π»ΡΠ»ΠΎΡΡ ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΉ ΠΏΡΠΈΡΠΈΠ½ΠΎΠΉ ΠΎΡΠΊΠ°Π·Π°). Π‘ΡΠ΅Π΄ΠΈ ΠΎΡΠ½ΠΎΠ²Π½ΡΡ
ΠΌΠΎΡΠΈΠ²ΠΎΠ² ΠΆΠ΅Π»Π°Π½ΠΈΡ Π·Π½Π°ΡΡ ΡΠΈΡΠΊ ΠΎΡΠΌΠ΅ΡΠ°Π»ΠΈΡΡ ΡΠ»Π΅Π΄ΡΡΡΠΈΠ΅: ΠΎΡΡΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΡΠΈΡΡΠ°ΡΠΈΠΈ ΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ΅Ρ (78 %), ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅ΠΉ ΠΆΠΈΠ·Π½ΠΈ Π΄Π»Ρ ΡΠ΅Π±Ρ ΠΈ/ΠΈΠ»ΠΈ Π±Π»ΠΈΠ·ΠΊΠΈΡ
(47 %), Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΡΡΠ°ΡΡΠΈΡ Π² ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠ°Ρ
Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΌΠ΅ΡΠ°ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΎΡΠΌΡ Π£Π (35 %), ΠΏΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΈ ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΈ (28 %). ΠΠΎΡΠΈΠ²Ρ Π΄Π»Ρ ΠΎΡΡΡΡΡΡΠ²ΠΈΡ ΡΠ°ΠΊΠΎΠ³ΠΎ Π½Π°ΠΌΠ΅ΡΠ΅Π½ΠΈΡ ΡΠ²ΡΠ·Π°Π½Ρ ΡΠΎ ΡΡΡΠ°Ρ
ΠΎΠΌ ΠΏΠ΅ΡΠ΅Π΄ Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ΠΌ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΎΠ² ΠΈ Π½Π΅Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡΡ ΡΡΠ°Π±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΠΈ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΠΏΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ.ΠΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΈΡΠΊΠ° ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΡΠ²Π»ΡΠ΅ΡΡΡ Π²Π°ΠΆΠ½ΠΎΠΉ ΡΠΎΡΡΠ°Π²Π»ΡΡΡΠ΅ΠΉ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Π° Π² Π²Π΅Π΄Π΅Π½ΠΈΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠΎΠΉ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ ΠΎΡΠ³Π°Π½ΠΎΡΠΎΡ
ΡΠ°Π½ΡΡΡΠ΅Π³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ. ΠΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π½Π° Π±ΡΠ΄ΠΆΠ΅ΡΠ½ΠΎΠΉ ΠΎΡΠ½ΠΎΠ²Π΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ ΠΏΠΎΠ²ΡΡΠΈΡΡ ΡΡΠΎΠ²Π΅Π½Ρ ΡΠ΄ΠΎΠ²Π»Π΅ΡΠ²ΠΎΡΠ΅Π½Π½ΠΎΡΡΠΈ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΡΡΠ΅Π±Π½ΠΎΡΡΠ΅ΠΉ Ρ Π΄Π°Π½Π½ΠΎΠΉ ΠΊΠ°ΡΠ΅Π³ΠΎΡΠΈΠΈ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΈ ΡΠ»ΡΡΡΠΈΡΡ ΠΏΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΌΠ΅ΡΠ°ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² ΡΠ²Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ
- β¦